ConductScience.org, home

Paper41728076

Porphyrin-coated gold nanoparticles associated with X-rays and proton therapy in the treatment of triple-negative breast cancer.

Silva CR and 3 others. Nanoscale Adv, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Porphyrin-coated gold nanoparticles associated with X-rays and proton therapy in the treatment of triple-negative breast cancer. Papers, record 41728076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41728076

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Porphyrin-coated gold nanoparticles associated with X-rays and proton therapy in the treatment of triple-negative breast cancer.
PubMed
Journal
Nanoscale Adv
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Silva CRCamila Ramoshttps://orcid.org/0000-0003-2081-3319
2Berionni GGuillaumehttps://orcid.org/0000-0002-5422-9113
3Ribeiro MSMartha Simõeshttps://orcid.org/0000-0002-4203-1134
4Heuskin ACAnne-Catherine

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137513983Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook.Pharmaceutics2023https://conductscience.org/library/papers/37513983PubMed
229338744New insights in the relative radiobiological effectiveness of proton irradiation.Radiat Oncol2018https://conductscience.org/library/papers/29338744PubMed
325602130Nanoparticles in photodynamic therapy.Chem Rev2015https://conductscience.org/library/papers/25602130PubMed
431650249Investigation of combined photodynamic and radiotherapy effects of gallium phthalocyanine chloride on MCF-7 breast cancer cells.J Biol Inorg Chem2020https://conductscience.org/library/papers/31650249PubMed
536975432The Potential of Proton Therapy for Locally Advanced Breast Cancer: Clinical and Technical Considerations.Curr Oncol2023https://conductscience.org/library/papers/36975432PubMed
620121172One-phase synthesis of water-soluble gold nanoparticles with control over size and surface functionalities.Langmuir2010https://conductscience.org/library/papers/20121172PubMed
736868521Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.Int J Radiat Oncol Biol Phys2023https://conductscience.org/library/papers/36868521PubMed
836623701Research progress of potential factors influencing photodynamic therapy for gastrointestinal cancer.Photodiagnosis Photodyn Ther2023https://conductscience.org/library/papers/36623701PubMed
934575408Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions.Pharmaceutics2021https://conductscience.org/library/papers/34575408PubMed
1036218130Photodynamic therapy in breast cancer treatment.J Appl Biomed2022https://conductscience.org/library/papers/36218130PubMed
1135613354Mechanisms and mathematical modeling of ROS production by the mitochondrial electron transport chain.Am J Physiol Cell Physiol2022https://conductscience.org/library/papers/35613354PubMed
1230427254The role of thioredoxin reductase in gold nanoparticle radiosensitization effects.Nanomedicine (Lond)2018https://conductscience.org/library/papers/30427254PubMed
1339776332Photodynamic therapy as a strategic ally in radiotherapy for triple-negative breast cancer: the importance of treatment order.Breast Cancer Res Treat2025https://conductscience.org/library/papers/39776332PubMed
1430791480Thioredoxin Reductase Activity Predicts Gold Nanoparticle Radiosensitization Effect.Nanomaterials (Basel)2019https://conductscience.org/library/papers/30791480PubMed
1521082814Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response.ACS Nano2010https://conductscience.org/library/papers/21082814PubMed
1629491463Target delivery of doxorubicin tethered with PVP stabilized gold nanoparticles for effective treatment of lung cancer.Sci Rep2018https://conductscience.org/library/papers/29491463PubMed
1721262347Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay.Free Radic Biol Med2011https://conductscience.org/library/papers/21262347PubMed
1827184417Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.Nat Rev Clin Oncol2016https://conductscience.org/library/papers/27184417PubMed
1925361443Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.Phys Med Biol2014https://conductscience.org/library/papers/25361443PubMed
2033262595Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.Int J Nanomedicine2020https://conductscience.org/library/papers/33262595PubMed

See all 42 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42883253Porphyrin-Based Compounds in Medicine: From Photodynamic Therapy to Theranostics.Molecules2026https://conductscience.org/library/papers/42883253PubMed
42559173Illumination of Targeting Nanotherapeutics with Precision Eyes: From Optical to Radio-nanotheranostics.Theranostics2026https://conductscience.org/library/papers/42559173PubMed
42074099Application Advances of Gold Nanoparticles in Cancer Theranostics: From Physicochemical Mechanisms to Multifunctional Nanoplatforms.Int J Mol Sci2026https://conductscience.org/library/papers/42074099PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PRDX525824PubTator's text mininghttps://conductscience.org/library/genes/25824

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41728076

GET https://conductscience.org/api/papers/v1/41728076/references?page=2